Oculus Innovative Sciences Announces Fiscal Third Quarter 2013 Financial Results and Conference Call

Oculus Innovative Sciences Announces Fiscal Third Quarter 2013 Financial
Results and Conference Call

PETALUMA, Calif., Jan. 31, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative
Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for
its fiscal third quarter 2013, ended December 31, 2012, will be released after
the U.S. market closes on February 13, 2013. The earnings release will be
followed by a conference call at 1:30 p.m. PT (4:30 p.m. ET) on February 13,
2013, to discuss fiscal third quarter results.

Individuals interested in participating in the conference call may do so by
dialing 877-303-7607 for domestic callers or 973-638-3203 for international
callers. Those interested in listening to the conference call live via the
Internet may do so at http://ir.oculusis.com/events.cfm.Please log on
approximately 30 minutes prior to the presentation in order to register and
download the appropriate software.

A telephone replay will be available for seven days following the conclusion
of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for
international callers, and entering conference code 90051967. A webcast replay
will be available on the site at http://ir.oculusis.com/events.cfm for one
year following the call.

About Oculus Innovative Sciences

Oculus Innovative Sciences is a commercial healthcare company that designs,
produces and markets innovative, safe and effective drugs, devices, and
nutritional products. Oculus is pioneering innovative solutions in multiple
markets for the dermatology, surgical, wound care, and animal healthcare
markets, and has commercialized products in the United States, Europe, India,
China, Mexico and select Middle East countries. The company's headquarters are
in Petaluma, California, with manufacturing operations in the United States
and Latin America. More information can be found at www.oculusis.com.

CONTACT: Media and Investor Contact:

         Oculus Innovative Sciences, Inc.
         Dan McFadden
         Director of Public and Investor Relations
         (425) 753-2105
         dmcfadden@oculusis.com
 
Press spacebar to pause and continue. Press esc to stop.